Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page reflects an update to the site’s revision version from v3.5.2 to v3.5.3, indicating an underlying platform/admin release rather than content changes to the trial record.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.5.2 was added; Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision notes show the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision tag on the page was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedThe sponsor and affiliated institution names were updated to the official designation: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The page now lists Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) and removes the alternate aliases to standardize naming.SummaryDifference0.3%

- Check88 days agoChange DetectedFooter updated to revision v3.4.2 (from v3.4.1); no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.